SCHEMBL20737207

SCHEMBL20737207

CCc1nc2ccccc2n1-c1ccc(-c2cc3c(c4ccccc24)-c2cc4ccccc4cc2C32c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.37
CYP1A2 P05177 2/20 0.37
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
BMI1 P35226 4/20 0.33
SCN9A Q15858 1/20 0.33
KCNH2 Q12809 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HKDC1 Q2TB90 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
FLT3 P36888 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20737211 0.93 CYP1A2 (0.39) PDE10ACYP1A2MAPTMEN1HPGD
SCHEMBL20736543 0.91 PDE10A (0.36) PDE10ACYP1A2MAPTKDM4EMEN1
SCHEMBL20737204 0.90 MAPK1 (0.43) PDE10ACYP1A2KDM4EALDH1A1SMN1; SMN2
SCHEMBL27250489 0.89 PDE10A (0.37) PDE10ACYP1A2MAPTKDM4EMEN1
SCHEMBL27250525 0.88 CYP1A2 (0.37) PDE10ACYP1A2MAPTKDM4EMEN1
SCHEMBL20737162 0.87 PDE10A (0.36) PDE10ACYP1A2MAPTKDM4EMEN1
SCHEMBL20737205 0.87 ESR1 (0.46) MAPTKDM4EMEN1ALDH1A1HPGD
SCHEMBL20736629 0.86 ESR1 (0.41) MAPTKDM4EMEN1ALDH1A1HPGD
SCHEMBL27250599 0.85 PDE10A (0.41) PDE10ACYP1A2MAPTKDM4EMEN1
SCHEMBL20736540 0.84 USP2 (0.41) PDE10ACYP1A2MAPTMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MAPT 1713/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MAPT 1713/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDE10A 4099/4885CYP1A2 739/4885MAPT 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.